Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RHNO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HBS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927746 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NAP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM208A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN2AIPNL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATPAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929177 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM72A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRP1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on